, opens new tab The updated vaccine is authorized for use in individuals 12 years of age and older and will target the JN.1 strain of the virus. ...

 

The updated vaccine targets the 'parent strain' of currently circulating variants, and has shown robust cross-reactivity against JN.1 lineage viruses, including KP.2.3, KP.3, KP.3.1.1 and LB.1, said CEO John Jacobs.Earlier this month, the health regulator approved updated COVID-19 vaccines made by Pfizer (PFE.N) , opens new tab and Moderna (MRNA.O), opens new tab targeting the KP.2 variant.

...